Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

McKesson Corp (NY: MCK )

531.47 -0.53 (-0.10%)
Streaming Delayed Price Updated: 12:00 PM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about McKesson Corp

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
The FDA approved Calliditas Therapeutics AB's (NASDAQ: CALT) Tarpeyo (budesonide) delayed-release capsules to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy... 
Via Benzinga
Exposures Product Safety
Here's How Much You Would Have Made Owning McKesson Stock In The Last 5 Years
Via Benzinga
What 5 Analyst Ratings Have To Say About McKesson
Via Benzinga
How Is The Market Feeling About McKesson?
Via Benzinga
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
New growth drivers are helping to propel these reliable and steady businesses. 
Via The Motley Fool
Here's How Much $100 Invested In McKesson 15 Years Ago Would Be Worth Today
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $13,000 Today
Via Benzinga
(MCK) - Analyzing McKesson's Short Interest
Via Benzinga
Peering Into McKesson's Recent Short Interest
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Biotech Stocks You’ll Regret Not Buying Soon: November 2023
The global biotechnology market could nearly triple by 2030. Investors should consider buying these biotech stocks before they explode. 
Via InvestorPlace
Qualcomm, Merck And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed lower by more than 100 points on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
3 Evergreen Stocks for Long-term Wealth Generation
Finding solid long-term stocks that aren't value traps is tough, but these stocks have great fundamentals and equally compelling prospects. 
Via InvestorPlace
Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review
Bulls are back in control as the major indexes confirmed the uptrend this week. 
Via Investor's Business Daily
Analyst Ratings for McKesson
Via Benzinga
McKesson (MCK) Q2 2024 Earnings Call Transcript
MCK earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Top 3 Blue-Chip Stocks in the Healthcare Industry
These are some of the best healthcare blue-chip stocks by market capitalization, offering great returns for investors. 
Via InvestorPlace
McKesson Unusual Options Activity For November 01
Via Benzinga
Earnings Due For Stealth GLP-1 Weight-Loss Drug Play McKesson, Rivals
McKesson earnings are on tap, with Cencora and Cardinal Health due soon. 
Via Investor's Business Daily
Fear & Greed Index Remains In 'Fear' Zone Ahead Of Fed's Decision
The CNN Money Fear and Greed index remained in the "Fear" zone on Tuesday. U.S. stocks closed higher on Tuesday, ahead of the Federal Reserve's monetary policy decision. The central bank is widely... 
Via Benzinga
Topics Economy
Exposures Interest Rates
A Preview Of McKesson's Earnings
Via Benzinga
Here's How Much $1000 Invested In McKesson 20 Years Ago Would Be Worth Today
Via Benzinga
Peering Into McKesson's Recent Short Interest
Via Benzinga
Kraft Heinz, Yum China And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
McKesson Aims For The $500 Milestone After Shattering Previous Record Highs And Outperforming The S&P 500!
Amidst the S&P 500's 7% decline since July, McKesson Corp's stock has notably risen by 12%. McKesson has experienced a rise since December 2018 of 347%. McKesson's Q2 earnings estimate stands at... 
Via Benzinga
Topics Stocks
Exposures US Equities
7 Healthcare Stocks That Can Cure a Lackluster Portfolio
Take a position in these companies' stocks to achieve long-term gains and give a jolt to your investment portfolio. 
Via InvestorPlace
Bankrupt Rite Aid, McKesson Strike Deal To Secure Steady Drug Deliveries
Rite Aid Corporation (NYSE: RAD) and drug supplier McKesson Corp (NYSE: MCK) have reached a settlement, securing the continued fulfillment of customer prescriptions throughout Rite Aid's  
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
$100 Invested In This Stock 10 Years Ago Would Be Worth $300 Today
Via Benzinga
$100 Invested In McKesson 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Privatized Vaccine Distribution Sparks Confusion, Payment Challenges
As the rollout of the updated COVID-19 vaccine progresses, some individuals have been surprised by requests for upfront payments ranging from $150 to $200.  
Via Benzinga
Exposures COVID-19
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.